Skip to main content

Assessment of the novel soft mist Pre-filled Syringe Inhaler (PFSI) device performance after storage at sub 0 °C temperature conditions

11 December, 2024

Authors: Imco Sibum, Bernhard Müllinger, and Nicolas A. Buchmann

Event: DDL 2024, 11 – 13 December 2024, Edinburgh, United Kingdom

Abstract: Resyca’s PFSI device maintains anti-microbial ingress valve and delivery performance post-storage at freezing conditions.


This finding further demonstrates the suitability of Resyca’s technology for the delivery of biological products such as proteins and RNA based formulations, where maintaining sterility without preservatives is important and which are frequently stored at sub 0 conditions.

Download
Contact